Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.50
Bid: 15.00
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 1.00 (6.667%)
Open: 15.50
High: 15.50
Low: 15.50
Prev. Close: 15.50
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half year trading update

2 Oct 2023 07:00

RNS Number : 2625O
Thruvision Group PLC
02 October 2023
 

2 October 2023

Thruvision Group plc

 

Half year trading update

 

Thruvision (AIM:THRU, "Thruvision" or the "Group"), the leading provider of walk-through security technology, today publishes a trading update for the six months to 30 September 2023 ("H1 2024").

 

Trading in the six month period has shown good momentum. Revenue grew by an estimated 27% to approximately £3.5 million (H1 2023: £2.8 million) with an order backlog at 30 September of £1.0 million expected to be delivered early in the third quarter. Cash at 30 September 2023 was £2.3 million (30 September 2022: £1.1 million) and trade receivables were £2.7 million (30 September 2022: £3.3 million).

 

Customs market revenue grew by 16% underpinned by a major contract win with a new Asian customer. In addition, an order was received from a new Central American customs agency late in the period, maintaining momentum in this market. In Retail Distribution, the Group added new customers including GXO, the global logistics provider and TD Synnex, a global technology provider. There was also renewed demand from the international Entrance security market, which is expected to continue.

 

In contrast to the encouraging progress elsewhere, the anticipated order from US Customs and Border Protection (CBP) did not get awarded in September, due to US Federal Government and Departmental budget challenges. Without the CBP order there will be a material impact on the Group's performance in the second half and for the current financial year as a whole.

 

With an encouraging pipeline of opportunities, it is anticipated that second half revenue will exceed that of the first half. However, without a CBP equipment order this year, it is unlikely that full year revenue will meet current market expectations.

 

Colin Evans, Chief Executive, commented:

 

"It is frustrating that, because of US Federal budgetary challenges, we have not received our anticipated CBP order this year. CBP continues to operate a significant fleet of our units very successfully across many ports of entry into the US and we continue to support these deployments. We fully expect further significant CBP orders when clearer priorities for border control investment are established by the US Government.

 

"Despite this single disappointment, we are seeing increasing traction internationally and we secured six new customers in the first half across our markets. We are confident that interest levels in our unique solutions, particularly WalkTHRU, which has the ability to screen 100% of people for all types of concealed items at walking pace, remain strong.

 

"We expect, therefore, that the second half will demonstrate good revenue growth over the first and will be based on a more diversified range of customers."

 

 

For further information please contact:

 

Thruvision Group plc                                                                                                   +44 (0)1235 425400

Colin Evans, Chief Executive

Victoria Balchin, Chief Financial Officer

 

Investec Investment Banking (NOMAD & Broker)                                          +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

Meare Consulting                                                                                                          +44 (0) 7990 858548

Adrian Duffield

 

About Thruvision (www.thruvision.com)

 

Thruvision is the leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 20 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group's offices are near Oxford and Washington DC.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLRITLLIIV
Date   Source Headline
24th Oct 20197:00 amRNSSharesave option grant to Executive Director
8th Oct 20192:00 pmRNSAward of Share Options to Executive Directors
3rd Oct 20197:00 amRNSTrading Update
23rd Sep 20191:29 pmRNSResult of Annual General Meeting
23rd Sep 20197:00 amRNSContract award announcement
16th Sep 20193:36 pmRNSThruvision trialed in London Underground station
8th Jul 20192:14 pmRNSNotice of Audited Results
24th Jun 20197:00 amRNSResults for the Year ended 31 March 2019
20th Jun 20197:00 amRNSNotice of Results
22nd May 20197:00 amRNSContract award announcement
1st May 20197:00 amRNSAppointment of Finance Director
2nd Apr 20197:00 amRNSPre-close Trading Update
7th Feb 20197:00 amRNSCapital Markets Day
18th Jan 20194:02 pmRNSAward of Share Options to Executive Directors
10th Dec 20187:00 amRNSInterim Results
3rd Dec 201812:52 pmRNSNotice of Results
2nd Nov 20181:24 pmRNSTSA Concept of Operations Development Contract
3rd Oct 20187:00 amRNSTrading Update
21st Sep 20183:57 pmRNSSharesave option grant to Executive Directors
21st Sep 201810:21 amRNSAGM Statement
7th Sep 20185:10 pmRNSHolding(s) in Company
7th Sep 20185:07 pmRNSHolding(s) in Company
24th Aug 20189:19 amRNSAmendment - Holding(s) in Company
22nd Aug 201811:30 amRNSHolding(s) in Company
21st Aug 201810:52 amRNSHolding(s) in Company
20th Aug 20183:04 pmRNSHolding(s) in Company
20th Aug 20182:53 pmRNSHolding(s) in Company
9th Aug 201812:30 pmRNSAnnouncement of Results of Tender Offer
31st Jul 20189:00 amRNSHolding(s) in Company
24th Jul 201810:21 amRNSResults of General Meeting/Tender Offer
4th Jul 20187:00 amRNSProposed Tender Offer & Notice of General Meeting
26th Jun 20187:00 amRNSAudited results for the full year 31 March 2018
21st Jun 201811:26 amRNSNotice of Audited Results
1st May 20183:53 pmRNSCapital Reduction Effective
28th Mar 20183:25 pmRNSResult of General Meeting
15th Mar 20185:13 pmRNSHolding(s) in Company
15th Mar 20182:00 pmRNSHolding(s) in Company
15th Mar 20187:00 amRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNSAward of Share Options to Executive Director
13th Mar 20185:29 pmRNSHolding(s) in Company
13th Mar 20183:40 pmRNSHolding(s) in Company
13th Mar 20183:17 pmRNSHolding(s) in Company
12th Mar 20182:05 pmRNSSecond Price Monitoring Extn
12th Mar 20182:02 pmRNSPrice Monitoring Extension
12th Mar 20187:01 amRNSShare Premium Account & Capital Redemption Reserve
12th Mar 20187:00 amRNSTrading Update & Return of Capital
8th Mar 20184:48 pmRNSHolding(s) in Company
27th Feb 20183:21 pmRNSHolding(s) in Company
26th Feb 20184:41 pmRNSSecond Price Monitoring Extn
26th Feb 20184:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.